https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos conocimientos y cambios de conceptos es histórico No hay dogmas nada está escrito en piedra.@CardiologiaSVC @SIAC_cardio @mencardio @torresviera @fernando_wyss https://t.co/RcpAtoTNPw
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Apr 2020 – Jul 2024Where it's discussed
-
X / Twitter199 posts
-
News87 articles
-
Facebook14 posts
-
Blogs5 articles
-
YouTube2 videos
-
Bluesky1 posts
AI synopsis
What people are saying
The discussions frequently mention specific concerns related to thrombotic complications during COVID-19, with phrases like 'critical insights' and 'important findings' to describe the publication's relevance. The use of terms like 'must read' and references to other studies reinforce a shared enthusiasm and urgency in considering the article's implications.
Many discussions reflect a general alignment with the findings, highlighting the significance of the publication.
There is a strong curiosity evident, as users frequently mention key aspects of the study.
Some posts delve into methodologies and clinical implications, showing thoughtful commentary.
Participants believe the research could significantly influence treatment strategies for COVID-19 patients.
Abstract in brief
- * Patients with existing thrombotic issues may face challenges when they contract COVID-19, affecting how their blood-thinning treatments are managed.
- * The authors discuss the importance of using technology to help treat not only COVID-19 patients but also those with thrombotic diseases during the pandemic.
Top posts
Most liked on X and BlueskyCOVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… https://t.co/u7JKC5hP5U
Kaynaklar: COVID-19 and Thrombotic or Thromboembolic Disease. J of Am College of Card (https://t.co/HvD7qimy2x) MAGELLAN (https://t.co/G9n9BnWVXq ) APEX (https://t.co/NY0S0WQ6ld) MARINER (https://t.co/oktiZ9GYfW
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… https://t.co/u7JKC5hP5U
COVID-19 y la enfermedad trombótica o tromboembólica: implicaciones para la prevención, la terapia antitrombótica y el seguimiento. https://t.co/wI29cKLKyG https://t.co/AZh7z35kRF
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. https://t.co/SAtxTysKrz
All mentions
Impact of Anticoagulation on Survival in COVID-19 Patients
Patients with COVID-19 treated with anticoagulants may have improved survival rates. A study published in the Journal of the American College of Cardiology 2020 reveals that optimized dosing of anticoagulants is…
Anticoagulation Impact on COVID-19 Patient Survival Rates
Patients with COVID-19 treated with anticoagulants may have improved survival chances, especially among those requiring mechanical ventilation. Autopsy findings from Hamburg revealed significant thromboembolic…
Tugas MindMap Cardiology 2208260250 RezaAddrianMechi
RT @MariolaPR: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC…
RT @MariolaPR: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC…
RT @MariolaPR: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC…
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review | Journal of the American College of Cardiology June 2020 https://t.co/3PU62116uW https://t.co/IkvGQZ0EuJ
@provaxtexan @handmadekathy @WendyOrent @Kathmarval @arcon_ryan @TonyBaduy @mcfunny @joltdude @BigBopp75348974 @krebiozen @swedishchf @RedPanda74 @littleLishka @EntrepreneurFg @_mamadeb @RadioColor @SkepticalMutant @MsTrixter @AndrewLazarus4 @crabb_vicki @100Dianne @FormerAntivax @GeoffSchuler @FrankDElia7 @1_TMF_ @TakethatCt @ScepticalAussie @runningrabbit_1 @groin_hammer @marcus66508078 @DeoOmniaVincit @doritmi @nia3in @LandmineLenny @Just4TheCause @GeneTherapy68 @hauxton @vinnumbskull @PaulVCooper1 @Tawdge @LauraDekker1 @emartinez78987 @bgspence @MAhealthforkids @pleasetellmeM @TinFoilAwards @Angel_13_Rising @7_DSSEVEN @JamesElijahMill @Charitable_Fury 2. Antibody-dependent enhancement.. making Covid worse and causing blood clots. Which it can do https://t.co/RReONtWXMx
RT @Doctorxy2: Kaynaklar: COVID-19 and Thrombotic or Thromboembolic Disease. J of Am College of Card (https://t.co/HvD7qimy2x) MAGELLAN (h…
RT @ABsteward: Just Published In Journal of the American College of Cardiology JAAC @ACCinTouch COVID-19 and Thrombotic or Thromboembolic D…
RT @iztyl90: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC St…
RT @iztyl90: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC St…
RT @iztyl90: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC St…
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review https://t.co/xkf4hIrZrI
RT @Doctorxy2: Kaynaklar: COVID-19 and Thrombotic or Thromboembolic Disease. J of Am College of Card (https://t.co/HvD7qimy2x) MAGELLAN (h…
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review https://t.co/m5M0T0lw0B
RT @Doctorxy2: Kaynaklar: COVID-19 and Thrombotic or Thromboembolic Disease. J of Am College of Card (https://t.co/HvD7qimy2x) MAGELLAN (h…
Kaynaklar: COVID-19 and Thrombotic or Thromboembolic Disease. J of Am College of Card (https://t.co/HvD7qimy2x) MAGELLAN (https://t.co/G9n9BnWVXq ) APEX (https://t.co/NY0S0WQ6ld) MARINER (https://t.co/oktiZ9GYfW
RT @klarrrk_man: #48 Bikdeli B, et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Thera…
#48 Bikdeli B, et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol 2020;75(23):2950–73. COVID-19と凝固の関連性強く示唆、動脈/静脈血栓症発症の可能性がある。 ↓
RT @Echoraljpangio: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up |…
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up | JACC: Journal of the American College of Cardiology https://t.co/WLnMTdRi15
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up • COVID-19 may predispose to arterial and venous thrombosis. • The optimal preventive strategy warrants further investigation. https://t.co/uqOnne87C1
RT @Bibliosaude: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up #Ayu…
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up https://t.co/wc2Y8MRLVj
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up #AyudaBiblioteca https://t.co/VLaCNL7Vwa https://t.co/QdX723p3Nl
RT @drsaavedra: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up JACC…
RT @drsaavedra: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up JACC…
RT @drsaavedra: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up JACC…
RT @drsaavedra: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up JACC…
RT @drsaavedra: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up JACC…
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up JACC State-of-the-Art Review https://t.co/4Fw41BXMWG https://t.co/jl0qYzv9hg
RT @ernestocardio: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up |…
RT @ernestocardio: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up |…
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up | JACC: Journal of the American College of Cardiology @jstragazue @drjarayg @recetario1 @mencardio https://t.co/W8wGEraS8L
RT @ethanjweiss: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up http…
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up https://t.co/GEWTwhTRuQ
RT @JuliaSellerm:
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up https://t.co/HIRH6iqCXt
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up | Read by QxMD https://t.co/OA0RfwyIPG
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… https://t.co/6nH322WcW5
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @GreggWStone: Our article "COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and F…
RT @DoctorSebastian: Terapia antitrombótica (anticoagulante) en COVID-19. https://t.co/cJcBB0aFpg https://t.co/Xf5vQWZ6C1
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. #coronavirus #covid19 https://t.co/hmC7R9bXya https://t.co/LpadVh9B4E
Great article: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. https://t.co/fCjsoLUf30 #ReadByQxMD
@fuxit4 https://t.co/DFczGnxTEr
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… https://t.co/HxfvXTL5Gm
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @DoctorSebastian: Terapia antitrombótica (anticoagulante) en COVID-19. https://t.co/cJcBB0aFpg https://t.co/Xf5vQWZ6C1
Terapia antitrombótica (anticoagulante) en COVID-19. https://t.co/cJcBB0aFpg https://t.co/Xf5vQWZ6C1
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. https://t.co/jeBoCV89lu
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
Publicación COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and ... https://t.co/jZol159szU #Hemostasia #Trombosis #Recursos
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… https://t.co/u7JKC5hP5U
RT @LuisZuritaG: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. htt…
RT @LuisZuritaG: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. htt…
RT @LuisZuritaG: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. htt…
@PacooGarcia @AleDiener @AnnalsofIM Terapia antitrombótica (anticoagulante). https://t.co/pYKfX4HEhm COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up [published online ahead of print, 2020 Apr 15]. J Am Coll Cardiol. 2020
RT @LuisZuritaG: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. htt…
RT @LuisZuritaG: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. htt…
RT @LuisZuritaG: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. htt…
RT @LuisZuritaG: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. htt…
RT @LuisZuritaG: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. htt…
RT @LuisZuritaG: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. htt…
RT @LuisZuritaG: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. htt…
RT @LuisZuritaG: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. htt…
RT @LuisZuritaG: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. htt…
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. https://t.co/SAtxTysKrz
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up - ScienceDirect https://t.co/fVtqtWWIHr
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up | JACC: Journal of the American College of Cardiology https://t.co/tLA6hS0x7w
RT @KirkmanBrent: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrobotic Therapy, and Follow-up. JAC…
RT @kdjhaveri: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up @Nort…
RT @kdjhaveri: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up @Nort…
RT @kdjhaveri: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up @Nort…
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up @NorthwellHealth https://t.co/I4O4AAj2Sa
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up @NorthwellHealth https://pubmed.ncbi.nlm.nih.gov/32311448/?from_term=+Northwell+covid+19&from_pos=2
#COVID-19 and #Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up - ScienceDirect https://t.co/vbpKlktbew
RT @grupoclaht: Publicación COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and ...…
Publicación COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and ... https://t.co/saC9ZekhUC #Hemostasia #Trombosis #Recursos
Além da lesão pulmonar causada pelo vírus, o sistema imunológico causa uma super reação que implica em muitos distúrbios como síndromes trombóticas https://t.co/LhBe0qKdt0
RT @surfshine1: 4月15日に出たばかりの最新論文によれば、コロナウィルスは強い炎症反応を引き起こすことによって、動脈と静脈の両方に血栓が生じるようです。両肺所見、突然の発症は血栓が肺に詰まった肺塞栓症で説明できます。肺炎ではなく肺塞栓なら、治療法も大きく異なって…
COVID-19 AND THROMBOTIC OR THROMBOEMBOLIC DISEASE: IMPLICATIONS FOR PREVENTION, ANTITHROMBOTIC THERAPY, AND FOLLOW-UP. Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. J Am Coll Cardiol. 2020 Apr 15. doi: 10.1016/j.jacc.2020.04.031. https://t.co/YAZDnVNMWf
4月15日に出たばかりの最新論文によれば、コロナウィルスは強い炎症反応を引き起こすことによって、動脈と静脈の両方に血栓が生じるようです。両肺所見、突然の発症は血栓が肺に詰まった肺塞栓症で説明できます。肺炎ではなく肺塞栓なら、治療法も大きく異なってきます。 https://t.co/hNbS0PCNXD
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. https://t.co/nwjNNYeKca
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up https://t.co/gpLOIIknUb
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @uchida_kawasaki: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up…
RT @uchida_kawasaki: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up…
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up | JACC: Journal of the American College of Cardiology https://t.co/e3yA9culrB COVID-19と血栓性または血栓塞栓性疾患:予防、抗血栓療法、およびフォローアップへの影響
Great article: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. https://t.co/nf2PWCdDs9 #ReadByQxMD
The Science Underlying COVID-19: Implications for the Cardiovascular System. https://t.co/jfiJffQifO COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. https://t.co/Y3afcCRaK3
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
@MVMadhavanMD @CIBERES COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. J Am Coll Cardiol. 2020 Apr 15. https://t.co/BV6iyj180p Included at COVID-19 & MEED https://t.co/HJyKaltzmQ
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
RT @mmonrealriete: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… htt…
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… https://t.co/u7JKC5hP5U
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-… https://t.co/Or0lCUzxTS
RT @MacDeptMed: Drs Eikelboom JW, Schulman S, Weitz JI et al. reviewed the current understanding of the pathogenesis, epidemiology, managem…
RT @MacDeptMed: Drs Eikelboom JW, Schulman S, Weitz JI et al. reviewed the current understanding of the pathogenesis, epidemiology, managem…
RT @MacDeptMed: Drs Eikelboom JW, Schulman S, Weitz JI et al. reviewed the current understanding of the pathogenesis, epidemiology, managem…
Drs Eikelboom JW, Schulman S, Weitz JI et al. reviewed the current understanding of the pathogenesis, epidemiology, management, and outcomes of patients with #COVIDー19 who develop venous or arterial #thrombosis. Read the full paper
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @IdiUcv: COVID-19 y la enfermedad trombótica o tromboembólica: implicaciones para la prevención, la terapia antitrombótica y el seguimie…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @IdiUcv: COVID-19 y la enfermedad trombótica o tromboembólica: implicaciones para la prevención, la terapia antitrombótica y el seguimie…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @IdiUcv: COVID-19 y la enfermedad trombótica o tromboembólica: implicaciones para la prevención, la terapia antitrombótica y el seguimie…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @IdiUcv: COVID-19 y la enfermedad trombótica o tromboembólica: implicaciones para la prevención, la terapia antitrombótica y el seguimie…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @IdiUcv: COVID-19 y la enfermedad trombótica o tromboembólica: implicaciones para la prevención, la terapia antitrombótica y el seguimie…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @IdiUcv: COVID-19 y la enfermedad trombótica o tromboembólica: implicaciones para la prevención, la terapia antitrombótica y el seguimie…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @IdiUcv: COVID-19 y la enfermedad trombótica o tromboembólica: implicaciones para la prevención, la terapia antitrombótica y el seguimie…
RT @IdiUcv: COVID-19 y la enfermedad trombótica o tromboembólica: implicaciones para la prevención, la terapia antitrombótica y el seguimie…
RT @IdiUcv: COVID-19 y la enfermedad trombótica o tromboembólica: implicaciones para la prevención, la terapia antitrombótica y el seguimie…
RT @IdiUcv: COVID-19 y la enfermedad trombótica o tromboembólica: implicaciones para la prevención, la terapia antitrombótica y el seguimie…
RT @IdiUcv: COVID-19 y la enfermedad trombótica o tromboembólica: implicaciones para la prevención, la terapia antitrombótica y el seguimie…
RT @IdiUcv: COVID-19 y la enfermedad trombótica o tromboembólica: implicaciones para la prevención, la terapia antitrombótica y el seguimie…
RT @IdiUcv: COVID-19 y la enfermedad trombótica o tromboembólica: implicaciones para la prevención, la terapia antitrombótica y el seguimie…
RT @IdiUcv: COVID-19 y la enfermedad trombótica o tromboembólica: implicaciones para la prevención, la terapia antitrombótica y el seguimie…
RT @IdiUcv: COVID-19 y la enfermedad trombótica o tromboembólica: implicaciones para la prevención, la terapia antitrombótica y el seguimie…
RT @IdiUcv: COVID-19 y la enfermedad trombótica o tromboembólica: implicaciones para la prevención, la terapia antitrombótica y el seguimie…
COVID-19 y la enfermedad trombótica o tromboembólica: implicaciones para la prevención, la terapia antitrombótica y el seguimiento. https://t.co/wI29cKLKyG https://t.co/AZh7z35kRF
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
RT @DrPontecarlosi: https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos co…
https://t.co/8mX5gsENtQ 1187 pacientes uso IECAS/ARA-2 ⏬ mortalidad pacientes #COVID19 + HTA La velocidad de nuevos conocimientos y cambios de conceptos es histórico No hay dogmas nada está escrito en piedra.@CardiologiaSVC @SIAC_cardio @mencardio @torresviera @fernando_wyss https://t.co/RcpAtoTNPw
CN
MM
SY
IU
LG
BC
M
FB
MR
J
S
HM
GC
S
TB
I
PP
DA
G
横
ク社
MD
DV
AC
ML
M
B
JV
JG
SF
EM
N
LF
FR
EH
SS
EW
AR
JS
DG
PP
EC
TI
C
Y
PE
DR
RM
ES
DH
CP
GB
KL
JG
TJ
O
SM
D
H
LL
GC
DM
F
JR
BV
HM
WL
JL
FZ
T
M
NG
K
L
K
RG
MD
KJ
D
LG
O
ΓΣ
ほH
T
JG
R
MV
MV
S
B
白即
内
PL
FD
M
N
LP
CM
MR
B
AC
RG
FA
AA
SM
AH
C
DJ
R
AO
CF
JC
FU
AR
MP
ED
MM
GL
F
AP
IM
CR
EA
IY
G
R
JR
MR
AU
LM
A
TP
SC
RV
F
RE
DP
T
JM
F
D
C
G
EC
V
L
X
WM
Z
FP
MZ
M
CS
JS
AH
MT
DS
VL
SC
M
G
MG
YL
AB
MC
LB
JS
TB
S
DC
JM
HQ
EF
JV
JL
HM
LE